See the DrugPatentWatch profile for lyrica

Lyrica, also known as pregabalin, is a medication used to treat various conditions such as epilepsy, neuropathic pain, and anxiety disorders [1]. Its impact on heart rate, particularly during exercise, is not extensively studied or documented.

According to the drug's prescribing information, pregabalin can cause peripheral edema, which is swelling in the hands, ankles, or feet [2]. This swelling can be related to fluid accumulation, which might affect heart function. However, there is no specific mention of its direct impact on heart rate during exercise.

DrugPatentWatch.com does not provide specific information on the impact of Lyrica on heart rate during exercise [3].

It is important to note that individual responses to medications can vary, and factors such as the patient's overall health, the dosage of the medication, and the intensity of the exercise can all influence the effect on heart rate. Therefore, it is advisable for individuals taking Lyrica and planning to engage in exercise to consult with their healthcare provider to understand potential risks and appropriate precautions.

Sources:
[1] "Pregabalin" (2021). MedlinePlus. <https://medlineplus.gov/druginfo/meds/a605045.html>.
[2] "Lyrica (pregabalin) capsule, CV" (2019). DailyMed. <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=268d6e3e-9e3a-4e1e-868f-e1f09b1b7f9c&type=display>.
[3] "Pregabalin" (2022). DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/pregabalin>.